Loading ...
further studies ... necessaryto discoverprostate cancer risk SNPs
by GWAS(passive) discovered byprostate cancer risk markers
Age , family history of prostate cancer and ethnicity are knownto influenceprostate cancer risk
breast and ovarian cancer history in family(passive) is strongly influenced byProstate cancer risk
Body fatnessstrongly influencesprostate cancer risk
some vitamins and mineralsmay influenceprostate - cancer risk
Fermented soy foods were not observedto influenceprostate cancer risk
some supplemental vitamins and mineralsmay influenceprostate - cancer risk
that individual - level factors act jointly with neighborhood - level social and built environment factorsto influenceprostate cancer risk
body mass in both younger and older adulthood and weight gain between these periods of lifemay influenceprostate cancer risk
the alleles that influence type II diabetes risk and glycemic traitsinfluenceprostate cancer risk
SNPs in certain AA metabolism genesmay influenceprostate cancer susceptibility
that SNPs in certain AA metabolism genesmay influenceprostate cancer susceptibility
by TURP(passive) Often Caused byProstate Cancer Bacteremia
the germlinemay influenceprostate cancer susceptibility
genesinfluenceprostate cancer metastasis
Defects in EPHB2may causesusceptibility to prostate cancer
the most important factorscausingprostate cancer metastasis
No genetic marker for prostate cancer(passive) has been discoveredProstate cancer screening
Worry or concern about prostate cancer ... a factorcould influencescreening for prostate cancer
No Effect on Overall Mortalitymay resultScreening for prostate cancer
a factorcould influencescreening for prostate cancer
Italian researchershave discoveredprostate cancer biomarkers
of both a digital rectal examination and a serum PSA(passive) is composedProstate cancer screening
the harmful interventional cascaderesultsfrom prostate cancer screening
Doctorsmight causeProstate cancer screenings
elevated testosterone levelscan causemetastatic prostate cancer
cancerous cells that have broken away from the tumor and then travel through the body through either the blood or the lymphatic system(passive) is caused byMetastatic prostate cancer
in the recipient(passive) was discoveredMetastatic prostate cancer
from swelling(passive) will be usually causedProstate cancer prostate cancer
Leach DA , Need EF , Toivanen R , Trotta AP , Palenthorpe HM , Tamblyn DJ , Kopsaftis T , England GM , Smith E , Drew PA , Pinnock CB , Lee P , Holst J , Risbridger GP , Chopra S , DeFranco DB , Taylor RA and Buchanan G. Stromal androgen receptor regulates the composition of the microenvironmentto influenceprostate cancer outcome
to later prostate cancer riskleadsto later prostate cancer risk
in formation of functional osteoclasts , evident by the presence of large osteoclast actin rings that are indicative of formation of sealing zones , a unique cell adhesion structures established at sites of osteoclast attachment to the bone surface [ 42 , 43resultsin formation of functional osteoclasts , evident by the presence of large osteoclast actin rings that are indicative of formation of sealing zones , a unique cell adhesion structures established at sites of osteoclast attachment to the bone surface [ 42 , 43
bone cellscausesbone cells
from the glandular tissueoriginatefrom the glandular tissue
bone cellscausesbone cells
to a reduction in prostate cancer mortalityhas ledto a reduction in prostate cancer mortality
of 10 proprietary genes that are differentially expressed in prostate cancer cellscomposedof 10 proprietary genes that are differentially expressed in prostate cancer cells
any symptomsdoes ... causeany symptoms
to an increased proportion of men being diagnosed with potentially curable prostate cancerhas ledto an increased proportion of men being diagnosed with potentially curable prostate cancer
in a lower risk of prostate cancer death for older menresultedin a lower risk of prostate cancer death for older men
in a relevant reduction in cancer mortality , greater than that reported in screening for breast or colorectal cancercan resultin a relevant reduction in cancer mortality , greater than that reported in screening for breast or colorectal cancer
in substantial overdiagnosis and unnecessary treatmenthas resultedin substantial overdiagnosis and unnecessary treatment
in substantial overdiagnosis and in unnecessary treatmenthas resultedin substantial overdiagnosis and in unnecessary treatment
to some unnecessary treatment RELATEDleadsto some unnecessary treatment RELATED
to more diagnoses of the disease ... but does not appear to affect prostate - cancer - related mortalityleadsto more diagnoses of the disease ... but does not appear to affect prostate - cancer - related mortality
in a relevant reduction in cancer mortality , greater than thatcan resultin a relevant reduction in cancer mortality , greater than that
in overdiagnosis and therefore overtreatment of prostate cancershas resultedin overdiagnosis and therefore overtreatment of prostate cancers
to an increase in diagnoses of the diseaseledto an increase in diagnoses of the disease
in a reduction in the mortality from prostate cancer of between 21 % and 44 %can resultin a reduction in the mortality from prostate cancer of between 21 % and 44 %
the disease at an earlier and more curable stagediscoversthe disease at an earlier and more curable stage
to the diagnosis of cancersleadsto the diagnosis of cancers
to early detection of the diseaseleadingto early detection of the disease
to a marked increase in the detection of earlier and smaller prostate cancersledto a marked increase in the detection of earlier and smaller prostate cancers
unnecessary anxietymight causeunnecessary anxiety
to diagnosis in some casesmay have ledto diagnosis in some cases
to high detection levelshas ledto high detection levels
to a reduction in mortalityleadsto a reduction in mortality
in the overdetection and thus overtreatment of indolent disease and the lack of clarity as to the definitive or best treatment for men diagnosed with localized prostate cancermay resultin the overdetection and thus overtreatment of indolent disease and the lack of clarity as to the definitive or best treatment for men diagnosed with localized prostate cancer
in patientswould ... resultin patients
to the diagnosis of a large proportion of localized and low - risk diseasehad ledto the diagnosis of a large proportion of localized and low - risk disease
to overdetection and overtreatment of some patientsleadsto overdetection and overtreatment of some patients
more harm than goodcould causemore harm than good
more harm than goodcausesmore harm than good
more harm than goodmay causemore harm than good
alsoresultsalso
to overtreatmentmay leadto overtreatment
to overdiagnosiscan leadto overdiagnosis
in overdiagnosishas resultedin overdiagnosis
overdiagnosis(passive) caused byoverdiagnosis
in 300 local men being testedresultedin 300 local men being tested